IL89248A - תכשירי רוקחות משולבים הכוללים בין היתר אינטרפרון-d/b a היבריד רקומביננטי ומוראמילפפטיד ושימושם - Google Patents

תכשירי רוקחות משולבים הכוללים בין היתר אינטרפרון-d/b a היבריד רקומביננטי ומוראמילפפטיד ושימושם

Info

Publication number
IL89248A
IL89248A IL8924889A IL8924889A IL89248A IL 89248 A IL89248 A IL 89248A IL 8924889 A IL8924889 A IL 8924889A IL 8924889 A IL8924889 A IL 8924889A IL 89248 A IL89248 A IL 89248A
Authority
IL
Israel
Prior art keywords
interferon
leu
component
hybrid
glu
Prior art date
Application number
IL8924889A
Other languages
English (en)
Other versions
IL89248A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL89248A0 publication Critical patent/IL89248A0/xx
Publication of IL89248A publication Critical patent/IL89248A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL8924889A 1988-02-13 1989-02-10 תכשירי רוקחות משולבים הכוללים בין היתר אינטרפרון-d/b a היבריד רקומביננטי ומוראמילפפטיד ושימושם IL89248A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888803365A GB8803365D0 (en) 1988-02-13 1988-02-13 Antiviral combination

Publications (2)

Publication Number Publication Date
IL89248A0 IL89248A0 (en) 1989-09-10
IL89248A true IL89248A (he) 1994-01-25

Family

ID=10631664

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8924889A IL89248A (he) 1988-02-13 1989-02-10 תכשירי רוקחות משולבים הכוללים בין היתר אינטרפרון-d/b a היבריד רקומביננטי ומוראמילפפטיד ושימושם

Country Status (15)

Country Link
US (1) US5137720A (he)
EP (1) EP0329609B1 (he)
JP (1) JP2781191B2 (he)
KR (1) KR0131077B1 (he)
AT (1) ATE99953T1 (he)
AU (1) AU623876B2 (he)
CA (1) CA1336578C (he)
DE (1) DE68912155T2 (he)
DK (1) DK62089A (he)
GB (1) GB8803365D0 (he)
IE (1) IE63493B1 (he)
IL (1) IL89248A (he)
NZ (1) NZ227944A (he)
PH (1) PH26919A (he)
ZA (1) ZA891053B (he)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218846B (he) * 1992-04-07 1994-01-11 Ciba Geigy
FR2702659B1 (fr) * 1993-03-19 1995-08-25 Vacsyn Sa Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
DK0689449T3 (da) * 1993-03-19 2003-03-03 Vacsyn Sa Præparater til anvendelse i humanterapi, kendetegnet ved kombination af et muramylpeptid med en cytokin
US5461512A (en) * 1993-11-30 1995-10-24 Eastman Kodak Company Zoom camera lens having three moving groups
EP0708085B1 (en) * 1994-10-19 2002-07-17 Novartis AG Antiviral ethers of aspartate protease substrate isosteres
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
KR100863632B1 (ko) 2000-03-31 2008-10-15 퍼듀 리서치 파운데이션 리간드-면역원 접합체를 사용한 치료 방법
EP1434603B1 (en) * 2001-09-28 2009-12-16 Purdue Research Foundation Method of treatment using ligand-immunogen conjugates
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US8168164B2 (en) * 2006-02-03 2012-05-01 Purdue Research Foundation Targeted conjugates and radiation
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
US20080317836A1 (en) * 2007-06-19 2008-12-25 Discovery Partners Llc Topical compositions for anti-aging skin treatment
RU2488405C1 (ru) * 2012-07-17 2013-07-27 Илья Александрович Марков Лекарственное средство, обладающее противовирусным, противовоспалительным, иммуномодулирующим и обезболивающим действием, для местного и наружного применения - герпферон 2
KR101658048B1 (ko) 2014-06-25 2016-09-20 한국생명공학연구원 포스파티딜콜린 합성경로 관여 물질을 포함하는 항바이러스용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS616000A (ja) * 1984-06-21 1986-01-11 木下　菊巳 回転色合せ盤
DE3685996T2 (de) * 1985-06-11 1993-01-14 Ciba Geigy Ag Hybrid-interferone.
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent

Also Published As

Publication number Publication date
KR890012670A (ko) 1989-09-18
IE63493B1 (en) 1995-05-03
EP0329609A3 (en) 1990-05-16
EP0329609A2 (en) 1989-08-23
EP0329609B1 (en) 1994-01-12
IL89248A0 (en) 1989-09-10
ATE99953T1 (de) 1994-01-15
IE890435L (en) 1989-08-13
AU623876B2 (en) 1992-05-28
CA1336578C (en) 1995-08-08
PH26919A (en) 1992-12-03
ZA891053B (en) 1989-10-25
DE68912155D1 (de) 1994-02-24
AU2894389A (en) 1989-08-17
DK62089A (da) 1989-08-14
GB8803365D0 (en) 1988-03-16
DE68912155T2 (de) 1994-06-16
KR0131077B1 (ko) 1998-04-17
DK62089D0 (da) 1989-02-10
NZ227944A (en) 1991-08-27
JP2781191B2 (ja) 1998-07-30
US5137720A (en) 1992-08-11
JPH021410A (ja) 1990-01-05

Similar Documents

Publication Publication Date Title
AU623876B2 (en) Novel preparation and method of use thereof
EP0440742B1 (en) Liposome immunoadjuvants containing il-2
US4774085A (en) Pharmaceutical administration systems containing a mixture of immunomodulators
JP4338214B2 (ja) エリトロポエチンの肺投与
US6565841B1 (en) Pulmonary administration of granulocyte colony stimulating factor
JP2002500159A (ja) 抗原刺激顆粒球媒介炎症を予防または軽減するための免疫刺激オリゴヌクレオチドの使用
WO1991001719A1 (en) Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
KR20210027381A (ko) 신규 면역조절 소분자
Barna et al. Activation of alveolar macrophage TNF and MCP-1 expression in vivo by a synthetic peptide of C-reactive protein
US5997858A (en) Stimulation of host defense mechanisms against tumors
EP0331635A2 (en) Preparations for treating bladder cancer
EP0955056A1 (en) Recombinant colony stimulating factor-1 for treatment of fungal infection
US20170095534A1 (en) Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunction
DE19746173A1 (de) Tumorvakzine
US20030017976A1 (en) Therapeutic properties of liposome-encapsulated immunomodulators
US5422105A (en) Use of recombinant colony stimulating factor 1
AU724190B2 (en) Stimulation of host defense mechanisms against tumors
Tanguay et al. In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A
EP0598905A1 (en) STABILIZED IL-1$g(a) PHARMACEUTICAL PREPARATION
Eppstein et al. Liposomal interferon-β: sustained release treatment of simian varicella virus infection in monkeys

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed